| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 223 |
| 1 | TACROLIMUS | 223 |
| 2 | INFLIXIMAB | 193 |
| 3 | MYCOPHENOLATE MOFETIL | 189 |
| 4 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 182 |
| 5 | TACROLIMUS OINTMENT 0.1% | 181 |
| 6 | ADALIMUMAB-AATY | 119 |
| 7 | ADALIMUMAB-ADAZ | 119 |
| 8 | PREDNISONE | 119 |
| 9 | ADALIMUMAB-FKJP | 118 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ISATUXIMAB | 44 | 0.0076 |
| 1 | IPTACOPAN | 6 | 0.0075 |
| 2 | TECLISTAMAB-CQYV | 17 | 0.0071 |
| 3 | ATOVAQUONE | 45 | 0.0055 |
| 4 | BISACODYL SUPPOSITORIES | 44 | 0.0034 |
| 5 | BISCODYL | 44 | 0.0033 |
| 6 | ADEFOVIR DIPIVOXIL | 4 | 0.0031 |
| 7 | BISACODYL | 44 | 0.0031 |
| 8 | ADALIMUMAB-FKJP | 118 | 0.0026 |
| 9 | PROPYLTHIOURACIL | 5 | 0.0024 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 44 | 0.0075 |
| 1 | Antimalarial [EPC] | 46 | 0.0044 |
| 2 | Antiprotozoal [EPC] | 46 | 0.0043 |
| 3 | Stimulant Laxative [EPC] | 44 | 0.0031 |
| 4 | Interleukin-17A Antagonist [EPC] | 43 | 0.0012 |
| 5 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 2 | 0.0011 |
| 6 | Complement 5a Receptor Antagonist [EPC] | 7 | 0.0010 |
| 7 | Aldehyde Dehydrogenase Inhibitor [EPC] | 1 | 0.0009 |
| 8 | Antimetabolite Immunosuppressant [EPC] | 18 | 0.0008 |
| 9 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 73 | 0.0007 |